固体瘤驱动的血管透性的局部机械生物学破坏:机械与化学刺激之间的竞争
Alejandro Martín-Contreras1, María Sarasquete-Martínez2, José Manuel García-Aznar1
1Department of Mechanical Engineering, Multiscale in Mechanical and Biological Engineering (M2BE), Aragon Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza, Spain.
Acta biomaterialia
|January 10, 2026
概括
瘤细胞在机械或生化方面以不同的方式破坏血管. 胰腺癌细胞使用机械力,而肺癌细胞使用生化信号,需要定制的血管正常化策略.
科学领域:
- 生物医学工程 生物医学工程
- 癌症生物学 癌症生物学
- 血管生物学 血管生物学
背景情况:
- 瘤微环境通过生物化学和生物力学约束导致异常的瘤血管.
- 目前的血管正常化策略主要集中在生物化学调制上,忽视了机械力量在内皮功能障碍中的作用.
研究的目的:
- 为了研究胰腺管腺癌 (PANC-1) 和肺腺癌 (A549) 瘤模型对内皮血管的明显机械生物学影响.
- 阐明不同的瘤类型诱导血管不稳定和内皮屏障功能障碍的特定机制.
主要方法:
- 利用微流体平台研究嵌入在两个不同的固体瘤模型 (PANC-1和A549) 中的三维内皮血管.
- 使用共聚焦显微镜进行内皮膜屏障损伤的空间分辨分析.
- 进行了瘤细胞系的蛋白质组分析和集成的实时成像,形态测量,生化分析和蛋白质组分析.
主要成果:
- 通过显著的机械力,PANC-1球体诱导了血管功能障碍,增加了血管直径,并通过细胞收缩性破坏了内皮屏障完整性.
- A549球体因生物化学调节而导致血管不稳定,包括细胞外基质降解和炎症性秘密体,导致异质内皮透性.
- 蛋白质组分析揭示了不同的途径:PANC-1中的细胞骨变化和A549.9中的细胞外矩阵重塑/促炎因素.
结论:
- 不同类型的瘤采用不同的机械生物学和生化机制来破坏内皮屏障功能并破坏瘤血管的稳定性.
- 突出了瘤衍生的机械力量在血管功能障碍中的关键作用,在传统策略中经常被忽视.
- 强调需要针对瘤的血管正常化策略,将机械生物学和生物化学方法整合起来,以有效地恢复内皮屏障.
相关概念视频
Cell-matrix's Response to Mechanical Forces
3.4K
In animal cells, the extracellular matrix allows cells within tissues to withstand external stresses and transmits signals from the outside of the cell to the inside. The extracellular matrix is extensive, and its composition varies between different types of tissues. For example, the reticular fibers and ground substance make up the ECM in loose connective tissue, while collagen and bone minerals make up the ECM of bone tissue.
Anchoring junctions mechanically attach a cell to the...
Anchoring junctions mechanically attach a cell to the...
3.4K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
Mechanism of Angiogenesis
6.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.6K


